NewAmsterdam Pharma Co. NV (NAMS)
27.32
+0.46
(+1.73%)
USD |
NASDAQ |
Aug 25, 16:00
27.34
+0.02
(+0.09%)
After-Hours: 18:44
NewAmsterdam Pharma 1 Year Total Returns (Daily) : 7.40% for Aug. 24, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| August 24, 2026 | 7.40% |
| August 21, 2026 | 14.03% |
| August 20, 2026 | 14.23% |
| August 19, 2026 | 16.69% |
| August 18, 2026 | 7.28% |
| August 17, 2026 | 7.30% |
| August 14, 2026 | 7.19% |
| August 13, 2026 | 3.53% |
| August 12, 2026 | 11.32% |
| August 11, 2026 | 13.34% |
| August 10, 2026 | 10.55% |
| August 07, 2026 | 21.78% |
| August 06, 2026 | 17.15% |
| August 05, 2026 | 26.18% |
| August 04, 2026 | 27.19% |
| August 03, 2026 | 29.18% |
| July 31, 2026 | 27.42% |
| July 30, 2026 | 26.88% |
| July 29, 2026 | 22.52% |
| July 28, 2026 | 19.47% |
| July 27, 2026 | 28.05% |
| July 24, 2026 | 26.72% |
| July 23, 2026 | 27.40% |
| July 22, 2026 | 38.25% |
| July 21, 2026 | 43.35% |
| Date | Value |
|---|---|
| July 20, 2026 | 33.65% |
| July 17, 2026 | 44.13% |
| July 16, 2026 | 48.42% |
| July 15, 2026 | 52.14% |
| July 14, 2026 | 50.16% |
| July 13, 2026 | 54.50% |
| July 10, 2026 | 60.13% |
| July 09, 2026 | 65.99% |
| July 08, 2026 | 78.97% |
| July 07, 2026 | 90.08% |
| July 06, 2026 | 75.82% |
| July 02, 2026 | 83.70% |
| July 01, 2026 | 93.03% |
| June 30, 2026 | 87.13% |
| June 29, 2026 | 82.39% |
| June 26, 2026 | 80.16% |
| June 25, 2026 | 73.10% |
| June 24, 2026 | 77.34% |
| June 23, 2026 | 72.43% |
| June 22, 2026 | 71.60% |
| June 18, 2026 | 63.90% |
| June 17, 2026 | 63.06% |
| June 16, 2026 | 52.86% |
| June 15, 2026 | 51.41% |
| June 12, 2026 | 44.56% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| ProQR Therapeutics NV | 7.52% |
| Pharming Group NV | -16.35% |
| argenx SE | 53.20% |
| Arcutis Biotherapeutics, Inc. | 55.02% |
| Damora Therapeutics, Inc. | 807.5% |